Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Hosted on MSN
Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study
Tryptamine’s phase 1b study of IV-infused psilocin meets all objectives Lead asset TRP-8803 found safe at low, mid and upper dose levels Planning underway to advance TRP-8803 in phase II trials ...
Tryptamine strengthens clinical development team with two key appointments Professor Marcel Mozafari appointed senior formulation scientist and Professor David Castle appointed consultant medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results